Crohn’s disease affects millions of people globally, with prevalence rates varying dramatically by region. In Europe alone, an estimated 2.5 million people live with the condition, and rates across Western Europe range from about 28 to 322 per 100,000 people. While it has traditionally been concentrated in North America and Northern Europe, diagnoses are rising in newly industrialized parts of the world, making it an increasingly global disease.
Where Crohn’s Is Most and Least Common
The highest rates of inflammatory bowel disease, the category that includes both Crohn’s and ulcerative colitis, cluster in a handful of wealthy, Western nations. Canada has the highest overall prevalence, with roughly 663 per 100,000 people living with IBD, followed by Norway at about 572 per 100,000. New Zealand leads the world in new diagnoses each year, with an incidence rate of approximately 45 per 100,000.
At the other end of the spectrum, Mexico reports the lowest rates, with fewer than 1 per 100,000 people diagnosed annually. The Western Pacific region, which includes much of East and Southeast Asia, also has notably low rates, with a prevalence of about 34 per 100,000. Across WHO regions, the Americas have the highest incidence at roughly 18 per 100,000 per year, while the Western Pacific sits at just 3 per 100,000.
This geographic pattern strongly suggests that environmental and lifestyle factors play a major role. Countries with higher levels of industrialization, urbanization, and Western-style diets consistently report more cases. That said, the gap is narrowing. Pediatric Crohn’s diagnoses have been climbing worldwide since the 1950s, and 67% of studies tracking childhood Crohn’s over time have found a significant increase in incidence. The rise is particularly notable in regions where the disease was once rare.
Urban vs. Rural Rates
One longstanding theory is that city living raises the risk, but the data is more nuanced than you might expect. In the United States, prevalence is roughly similar across settings: about 1.4% in suburban areas, 1.0% in central cities, and 1.2% in rural communities. The bigger difference between urban and rural areas isn’t how many people have the disease but how easily they can access specialized care for it.
Who Gets Diagnosed and When
Crohn’s disease most commonly appears between the ages of 15 and 30. This is the peak window for a first diagnosis, and about 20% of all cases are diagnosed during childhood. Roughly one in four patients first develops symptoms before age 18, and the incidence in children over 10 is clearly increasing across multiple countries.
In childhood, the highest annual incidence rates are 13.9 per 100,000 in North America and 12.3 per 100,000 in Europe. At the lowest end globally, pediatric incidence can be as low as 0.2 per 100,000. The overall rise in pediatric Crohn’s has been the main driver of increasing IBD numbers worldwide, while ulcerative colitis rates in children have stayed relatively flat.
Women appear to be affected more than men. A large study of the U.S. military healthcare population found IBD prevalence of 417 per 100,000 in females compared to 284 per 100,000 in males, putting women at roughly 1.5 times the risk. The disease is also most common in white populations compared to other ethnic groups, though this gap may partly reflect differences in diagnosis and access to care.
How Crohn’s Affects Life Expectancy
People with Crohn’s disease do face a modestly higher mortality risk than the general population, though the size of that risk has been debated for decades. The largest study on this topic, using medical records covering 6% of the British population, found an annual mortality rate of 1.6% in people with Crohn’s compared to 1.0% in matched controls. After adjusting for age, sex, and smoking, the risk of death was about 73% higher in Crohn’s patients.
A European cohort study found similar results: a 10-year risk of death of 10% compared to 7% expected in the general population. Being diagnosed after age 40, having disease in the colon, and having inflammatory (rather than stricturing or penetrating) disease behavior at diagnosis were all linked to higher mortality. However, when all these factors were analyzed together, the only independent predictor of death was age at diagnosis, with each additional year of age raising the risk.
Importantly, these elevated risks are population averages. Many people with Crohn’s live full lifespans, particularly with modern treatment. But the data does highlight that mortality rates in Crohn’s have not significantly decreased over the past several decades, suggesting there is still room for improvement in long-term outcomes.
A Disease Still on the Rise
The global trajectory of Crohn’s disease points clearly upward. Since 1950, 60% of pediatric Crohn’s studies have documented a significant increase in incidence. The pattern is consistent across continents: regions that industrialize see their rates climb. This makes environmental exposures, diet, sanitation practices, and antibiotic use leading suspects in driving the increase, though no single factor has been pinpointed as the cause.
For now, Crohn’s remains most concentrated in North America, Northern Europe, and Oceania. But as newly industrialized nations continue to report rising numbers, the disease is increasingly a global health concern rather than a Western one.